Wells Fargo & Company Novartis Ag Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Novartis Ag stock. As of the latest transaction made, Wells Fargo & Company holds 1,983,847 shares of NVS stock, worth $205 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,983,847

Previous 2,088,574 5.01%

Holding current value

$205 Million

Previous $222 Million 2.62%

% of portfolio

0.05%

Previous 0.05%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$106.13 - $120.89 $11.1 Million - $12.7 Million	-104,727 Reduced 5.01%	1,983,847 $228 Million
Q2 2024 Aug 13, 2024	BUY	$92.57 - $107.37 $7.26 Million - $8.42 Million	78,448 Added 3.9%	2,088,574 $222 Million
Q1 2024 May 10, 2024	BUY	$95.27 - $108.47 $626,686 - $713,515	6,578 Added 0.33%	2,010,126 $194 Million
Q4 2023 Feb 09, 2024	SELL	$92.27 - $101.54 $519,572 - $571,771	-5,631 Reduced 0.28%	2,003,548 $202 Million
Q3 2023 Nov 13, 2023	SELL	$94.73 - $105.13 $5.1 Million - $5.66 Million	-53,871 Reduced 2.61%	2,009,179 $205 Million
Q2 2023 Aug 15, 2023	SELL	$92.52 - $104.91 $9.04 Million - $10.2 Million	-97,661 Reduced 4.52%	2,063,050 $208 Million
Q1 2023 May 12, 2023	BUY	$80.03 - $92.81 $1.02 Million - $1.19 Million	12,795 Added 0.6%	2,160,711 $199 Million
Q4 2022 Feb 13, 2023	SELL	$75.55 - $92.52 $12.8 Million - $15.7 Million	-169,269 Reduced 7.3%	2,147,916 $195 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $23.2 Million - $27.2 Million	-311,335 Reduced 11.84%	2,317,185 $176 Million
Q2 2022 Aug 12, 2022	SELL	$80.52 - $93.75 $36.7 Million - $42.8 Million	-456,224 Reduced 14.79%	2,628,520 $222 Million
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $6.51 Million - $7.37 Million	-81,300 Reduced 2.57%	3,084,744 $271 Million
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $171 Million - $189 Million	-2,149,285 Reduced 40.44%	3,166,044 $277 Million
Q3 2021 Nov 15, 2021	SELL	$81.78 - $95.14 $6.58 Million - $7.66 Million	-80,504 Reduced 1.49%	5,315,329 $435 Million
Q2 2021 Aug 16, 2021	SELL	$85.24 - $94.15 $35.5 Million - $39.2 Million	-416,666 Reduced 7.17%	5,395,833 $492 Million
Q1 2021 May 13, 2021	SELL	$83.5 - $98.47 $45.1 Million - $53.2 Million	-540,304 Reduced 8.5%	5,812,499 $497 Million
Q4 2020 Feb 09, 2021	SELL	$78.07 - $94.43 $17.2 Million - $20.8 Million	-219,999 Reduced 3.35%	6,352,803 $600 Million
Q3 2020 Nov 05, 2020	SELL	$82.14 - $91.0 $150,809 - $167,076	-1,836 Reduced 0.03%	6,572,802 $572 Million
Q2 2020 Aug 13, 2020	SELL	$80.93 - $91.1 $5.39 Million - $6.07 Million	-66,643 Reduced 1.0%	6,574,638 $574 Million
Q1 2020 May 14, 2020	BUY	$70.67 - $99.01 $469 Million - $658 Million	6,641,281 New	6,641,281 $548 Million

Others Institutions Holding NVS

# of Institutions

1,434

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $222B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Novartis Ag Transaction History